02748nam a22003137u 4500001001000000003000400010005001700014008004100031040000800072041000800080084002900088100002000117245017500137260008600312300004600398490003100444520170500475650001902180650000902199650002802208650002402236650001802260650002302278650002502301651001902326651001002345830004402355856003502399pwiiw7400OSt20260516120019.0250922t2025    au ||||| |||| 00| ||eng d  cOSt  aeng  aF14aF23aL64aO142jelc1 aFrancis, Smitha10aPost-pandemic shifts in medical electronics GVCs and changing value dynamics amidst new digitalisation:  An analysis based on Indian subsidiaries of EU-based corporations  aWien :bWiener Institut für Internationale Wirtschaftsvergleiche (wiiw),c2025.  a59 S., b13 Tables and 29 Figures,c30cm.1 awiiw Research Reportsv479  aRealignments of global value chains (GVCs) are occurring at a time when the technological dynamics in manufacturing industries, including in healthcare-related industries like medical electronics, is undergoing significant changes due to the wave of new digitalisation. This study examines post-pandemic changes in global medical electronics value chains through industry-level trade analysis and the GVC participation of selected Indian subsidiaries of medical electronics companies based in the European Union (EU), focusing on the implications of digitalisation and data-centric strategies for capturing value. The study finds that post-COVID-19 realignments in the industry proceeded gradually until 2023. Meanwhile, digitalisation is leading to a gradual expansion in operations by EU-based medical device multinational corporations (MNCs) in India. This is shown to be due to the increased role of software for product design and process optimisation in digitalising value chains. Leading EU-based medical device MNCs are found to be leveraging India’s strengths in software design and data-analytics capabilities for co-developing their software-embedded ‘health systems’ and ‘solutions’. However, even when software and services exports from India went up with increasing digitalisation, the shares of the EU-based lead firm groups in total revenue of the Indian subsidiaries were found to increase. This occurred through imports of software-embedded medical devices and equipment along with imports of higher-valued proprietary software platforms, health systems and the like, which are patented and marketed by the EU-based lead firms or their foreign subsidiaries back to India.
  adigitalisation  aGVCs  amedical device industry  amedical electronics  aEuropean MNCs  avalue distribution  adigital value chains  aEuropean Union  aIndia 0v479wWIIW0000048twiiw Research Reports40uhttps://wiiw.ac.at/p-7400.html